共 17 条
[1]
[2]
[3]
[4]
[5]
The TWEAK ‐ Fn14 system as a potential drug target[J] Harald Wajant Br J Pharmacol 2013,
[6]
Deletion of Fn14 receptor protects from right heart fibrosis and dysfunction[J] Tatyana Novoyatleva;Yves Schymura;Wiebke Janssen;Frederic Strobl;Jakub M. Swiercz;Chinmoy Patra;Guido Posern;Astrid Wietelmann;Timothy S. Zheng;Ralph T. Schermuly;Felix B. Engel Basic Research in Cardiology 2013,
[7]
TWEAK/Fn14 promotes the proliferation and collagen synthesis of rat cardiac fibroblasts via the NF-кB pathway[J] Hui-Na Chen;De-Jin Wang;Man-Yi Ren;Qi-Lei Wang;Shu-Jian Sui Molecular Biology Reports 2012,
[8]
Differences in the predictive value of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in advanced ischemic and non-ischemic heart failure[J] Atherosclerosis 2010,
[9]
Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome[J] Emmanuel Chorianopoulos;Kai Jarr;Henning Steen;Evangelos Giannitsis;Norbert Frey;Hugo A. Katus Atherosclerosis 2010,
[10]
Tumour necrosis factor‐like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats[J] Acta Physiologica 2010,

